276 related articles for article (PubMed ID: 12749513)
1. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Castaldo RS; Celli BR; Gomez F; LaVallee N; Souhrada J; Hanrahan JP
Clin Ther; 2003 Feb; 25(2):542-57. PubMed ID: 12749513
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
3. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
Wasilewski MM; Johns D; Sides GD
J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
[TBL] [Abstract][Full Text] [Related]
4. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
Gaillat J
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
[TBL] [Abstract][Full Text] [Related]
5. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Hosie J; Quinn P; Smits P; Sides G
J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
Sides GD
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
[TBL] [Abstract][Full Text] [Related]
7. Dirithromycin: a new macrolide.
Wintermeyer SM; Abdel-Rahman SM; Nahata MC
Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
9. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
Shinkai I; Ohta Y
Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
[TBL] [Abstract][Full Text] [Related]
10. A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease.
Cazzola M; Caputi M; Santangelo G; Diu Vinciguerra A; Perna FD; Polverino M
J Chemother; 1997 Aug; 9(4):279-84. PubMed ID: 9269609
[TBL] [Abstract][Full Text] [Related]
11. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
Naderi N; Assayag D; Mostafavi-Pour-Manshadi SM; Kaddaha Z; Joubert A; Ouellet I; Drouin I; Li PZ; Bourbeau J
Respir Med; 2018 May; 138():129-136. PubMed ID: 29724384
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
13. Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
Swanson RN; Lainez-Ventosilla A; De Salvo MC; Dunne MW; Amsden GW
Treat Respir Med; 2005; 4(1):31-9. PubMed ID: 15725048
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease.
Matera MG; Tufano MA; Polverino M; Rossi F; Cazzola M
Eur Respir J; 1997 Jan; 10(1):98-103. PubMed ID: 9032500
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
Langley JM; Halperin SA; Boucher FD; Smith B;
Pediatrics; 2004 Jul; 114(1):e96-101. PubMed ID: 15231980
[TBL] [Abstract][Full Text] [Related]
16. Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis.
Cui Y; Luo L; Li C; Chen P; Chen Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():3813-3829. PubMed ID: 30538443
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of dirithromycin versus miocamycin in the treatment of acute bronchitis or acute exacerbations of chronic bronchitis.
Pozzi E
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():153-8. PubMed ID: 8478306
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
19. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
Vermeersch K; Gabrovska M; Deslypere G; Demedts IK; Slabbynck H; Aumann J; Ninane V; Verleden GM; Troosters T; Bogaerts K; Brusselle GG; Janssens W
Int J Chron Obstruct Pulmon Dis; 2016; 11():687-96. PubMed ID: 27099485
[TBL] [Abstract][Full Text] [Related]
20. Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.
Uzun S; Djamin RS; Kluytmans J; Van't Veer NE; Ermens AA; Pelle AJ; Mulder P; van der Eerden MM; Aerts J
Trials; 2012 Jun; 13():82. PubMed ID: 22682323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
